COMMUNIQUÉS West-GlobeNewswire

AxoGen Named Employee Engagement Best Practices Award Winner by DecisionWise International

27/02/2018 - 13:10

ALACHUA, Fla., Feb. 27, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced it has received a 2018 [...]

ADMA Biologics to Present at Raymond James’ 39th Annual Institutional Investors Conference

27/02/2018 - 13:08

RAMSEY, N.J. and BOCA RATON, Fla., Feb. 27, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA ) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical company that develops, [...]

Myriad Genetics to Present at Two Upcoming Healthcare Conferences

27/02/2018 - 13:05

SALT LAKE CITY, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled [...]

AxoGen, Inc. to Present at 30th Annual ROTH Conference

27/02/2018 - 13:00

ALACHUA, Fla., Feb. 27, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that Karen Zaderej, [...]

Recro Pharma Reports Year End 2017 Financial Results

27/02/2018 - 13:00

IV Meloxicam NDA Submitted and PDUFA Action Date Set for May 26, 2018 Record CDMO Performance; 2017 Revenues of $71.8 Million MALVERN, Pa., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue [...]

ProQR Supports Rare Disease Day 2018 and Honors Henri A. Termeer

27/02/2018 - 13:00

LEIDEN, the Netherlands, Feb. 27, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR ), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe [...]

Oxford Immunotec Reports Fourth Quarter and Full Year 2017 Financial Results

27/02/2018 - 13:00

2017 marks the 13 th consecutive year of at least 20% year-over-year constant currency revenue growth >25% pro forma organic growth for the year in tick-borne disease and other revenue Balance sheet strengthened by [...]

AMAG Reports 2017 Financial Results and Company Update

27/02/2018 - 13:00

2017 GAAP Revenue Increased 15% Year-over-Year February 2018: Company Secures Two U.S. Food and Drug Administration (FDA) Approvals Conference Call Scheduled for 8:00 a.m. ET Today WALTHAM, Mass., Feb. 27, 2018 (GLOBE [...]

Atara Biotherapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Recent Operational Progress

27/02/2018 - 13:00

– Initiated two Phase 3 clinical studies to evaluate tab-cel™ (tabelecleucel) in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder (EBV+ PTLD) who have failed rituximab and opened [...]

Exergen Corporation Senior Vice President Joins Northeastern University School of Nursing Faculty

27/02/2018 - 13:00

WATERTOWN, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Exergen Corporation is pleased to announce that its Senior Vice President and Chief Clinical Scientist, Dr. Marybeth Pompei, has accepted a new Affiliate Professor [...]

Optinose to Highlight Data at the 2018 AAAAI/WAO Joint Congress

27/02/2018 - 13:00

YARDLEY, Pa., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will [...]

Evogene Announces Positive Results in its Novel Mode-of-Action Herbicide Program

27/02/2018 - 13:00

REHOVOT, Israel, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ: EVGN )) (TASE: EVGN ), a leading biotechnology company developing novel products for life science markets through the use of a unique [...]

Pluristem’s PLX-R18 Improves Hematopoietic Transplantation as Reported in Scientific Journal Frontiers in Medicine

27/02/2018 - 13:00

HAIFA, Israel, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI ) (TASE: PSTI ), a leading developer of placenta-based cell therapy products, announced today that Frontiers in Medicine has [...]

GW Pharmaceuticals Receives Orphan Drug Designation from the European Medicines Agency (EMA) for Cannabidiol for the Treatment of Tuberous Sclerosis

27/02/2018 - 13:00

LONDON and CARLSBAD, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and [...]

Transactions in relation to share buyback program

27/02/2018 - 12:39

Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

Epizyme Announces Date of Fourth Quarter and Full Year 2017 Results Conference Call and Upcoming Presentation at the Cowen 38th Annual Health Care Conference

27/02/2018 - 12:30

CAMBRIDGE, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ: EPZM ), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that management will host a conference [...]

Avivagen Announces CEO Update and January 31, 2018 Financial First Quarter Results

27/02/2018 - 12:30

OTTAWA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“ Avivagen ” or the “ Company ”), a life sciences innovation company with a series of patent protected products that support and [...]

PotNetwork Holding Inc. Exceeds 1 Million in Sales for First 15 Days of February

27/02/2018 - 12:00

FT LAUDERDALE, Fla., Feb. 27, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- PotNetwork Holding, Inc. (OTC Pink:POTN ) (“Company”) announced today that its wholly owned subsidiary, Diamond CBD, Inc., has reported that the [...]

Integra LifeSciences Reports Fourth Quarter and Full-Year 2017 Financial Results

27/02/2018 - 12:00

PLAINSBORO, N.J., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART ) today reported financial results for the fourth quarter and full-year ended December 31, 2017. Highlights: [...]